Agilent Technologies, Inc.

Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for laboratory workflows, enabling customers to identify, quantify, and analyze the physical and biological properties of substances and products. Agilent operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. Its products include mass spectrometers, chromatography systems, and cell analysis platforms, serving a wide range of applications from pharmaceutical R&D to environmental testing.

Agilent generates revenue primarily from the sale of instruments, consumables, and services. In the latest fiscal year, the company reported $6.6 billion in total revenue, with roughly 40% from consumables, 30% from services, and 30% from instruments. The Diagnostics and Genomics segment contributes about 20% of revenue, while Life Sciences and Applied Markets accounts for over 50%. The company has a recurring revenue base from consumables and service contracts, providing stability. Recent quarterly revenue has been around $1.8 billion, with net income margins near 20%.

Agilent competes in the highly specialized diagnostics and research industry, alongside companies like Thermo Fisher Scientific, Danaher, and Waters. It holds a strong position in chromatography and mass spectrometry, with a reputation for precision and reliability. The industry is driven by innovation in life sciences and regulatory demands for quality testing. Agilent's focus on high-margin consumables and services, along with its broad portfolio, helps it maintain competitive advantage. The company's operating margin of 21% and gross margin of 52% reflect its value-added offerings.

Agilent serves a diverse customer base, including pharmaceutical and biotechnology companies, academic and government research institutions, clinical diagnostics labs, and environmental and food testing labs. Geographically, revenue is well-diversified: the Americas account for about 45%, Europe 25%, and Asia Pacific 30%, with China being a significant growth market. The company's products are used in drug discovery, quality control, and clinical diagnostics, making it a key partner in the healthcare and life sciences ecosystem.

An auto-generated descriptive profile based on company data, for informational purposes only.